Tokyo, June 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061725) titled 'A study to evaluate changes in exhaled nitric oxide (NO) before and after treatment in patients with chronic nasopharyngitis' on June 1.
Study Type:
Observational
Primary Sponsor:
Institute - Medical Corporation Mogitate (Mogitate ENT Clinic)
Condition:
Condition - Chronic nasopharyngitis
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - The objective of this study is to prospectively evaluate changes in oral and nasal exhaled nitric oxide (NO) before and after epipharyngeal abrasive therapy (EAT) in patients with chronic nasopharyngitis.
Basic objectives2 - Efficacy
Eligibility:
Age-lower limit - 15
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Patients diagnosed with chronic nasopharyngitis
Age 15 years or older
Patients initiating epipharyngeal abrasive therapy (EAT)
Written informed consent obtained
Key exclusion criteria - Patients with acute upper respiratory infection
Patients with acute exacerbation of asthma
Patients unable to perform exhaled NO measurement
Target Size - 45
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2026 Year 05 Month 18 Day
Date of IRB - 2026 Year 05 Month 21 Day
Anticipated trial start date - 2026 Year 06 Month 01 Day
Last follow-up date - 2026 Year 12 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000070645
Disclaimer: Curated by HT Syndication.
